Trials / Completed
CompletedNCT05104697
TMS for Improving Response Inhibition in Adolescents With OCD
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Bradley Hospital · Academic / Other
- Sex
- All
- Age
- 13 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The study will examine whether inhibition of the pre-supplementary motor area (pSMA) using transcranial magnetic stimulation (TMS) normalizes activity in pSMA-connected circuits, improves response inhibition, and reduces compulsions in adolescents with OCD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcranial Magnetic Stimulation | All teens will receive active TMS; they will be randomly assigned to receive active TMS at either visit 1 or visit 2 (order counterbalanced) |
Timeline
- Start date
- 2022-04-01
- Primary completion
- 2023-08-01
- Completion
- 2023-09-01
- First posted
- 2021-11-03
- Last updated
- 2025-01-28
- Results posted
- 2025-01-28
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05104697. Inclusion in this directory is not an endorsement.